Sustaining Proliferative Signaling and Evading Growth Suppressors

Slides:

Advertisements

Similar presentations

Signal Transduction Mechanisms Underlying Underlying Growth Control and Oncogenesis Ronit Sagi-Eisenberg Dept. of Cell and Developmental Biology Sackler.

Advertisements

Lecture 11: Signalling for Life/Death 1)Describe the eukaryotic cell cycle and the purpose of checkpoints. 2)Describe the role of cyclins and cyclin-dependent.

Plasma membrane Nuclear membranes Hormone receptor Adenylate cyclase ATP Active Protein Kinase A PO 4 G cAMP Inctive Protein Kinase A PO 4 Active pKA enters.

Lecture 23 Signal Transduction 2

Cell Signaling Lecture 10.

Chap. 16 Signaling Pathways That Control Gene Expression

Ligand Receptor Cortisol Receptor is located in the cytosol Retinoid Receptors are in the nucleus Target gene in the nucleus Regulation of Transcription.

Signal Transduction II Transduction Proteins & Second Messengers.

Cytoplasmic Signaling Circuitry Programs Many of the Traits of Cancer

Signal Transduction Biochemistry – February 23, 2005 Chapter 12 – parts 12.3, 12.4.

Signal Response and Amplification

CHAPTER 13 Insulin Signaling. Figure 13.1 – General mechanism of signal transduction across a membrane Steps involved: 1. Release of primary messenger.

Specialized signaling pathways 1: RTK associated pathways

Negative regulation of cell cycle by intracellular signals Checkpoint p53 detects DNA damage & activates p21 p21 inhibits cdk2-cyclinA Intracellular Regulation.

An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:

Date of download: 7/5/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Insulin signaling pathways. The insulin signaling pathways provide.

An Introduction to Medicinal Chemistry 3/e PROTEINS AS DRUG TARGETS:

Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.

Lung Cancer Tumour Markers

Model for regulation of the Ras p21 product and for the GTPase-activating protein (GAP) as a downstream effector and regulator of ras activity. Ras is.

Cell Signaling Pathways – A Case Study Approach

Receptor Tyrosine Kinases

Figure 1. Resistance mechanism against first generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI). (A) Mutations in the EGFR.

Intercellular Communication

OVERVIEW: Signals for cell surface receptors (hydrophilic):

Sustaining Proliferative Signaling and Evading Growth Suppressors

Hormones and Signal Transduction III

Sustaining Proliferative Signaling and Evading Growth Suppressors

Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.

TGFb –Superfamily Proteins

You have identified a novel cytoplasmic protein

Extracellular Regulation of Apoptosis

Figure 1 A schematic representation of the HER2 signalling pathway

Signal Transduction Through the Epidermal Growth Factor Receptor

by Walter Zumkeller, and Stefan Burdach

Figure 2 Oestrogen receptor signalling pathways

BDNF and insulin signaling pathways activated by phytochemicals.

Figure 1 mTOR complex biology

The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.

Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer Vassiliki Papadimitrakopoulou,

Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani Gastroenterology

Gonadotropin Signaling in the Ovary

Designing New Cellular Signaling Pathways

Figure 1 The insulin signalling pathway

An Emerging Role of mTOR in Lipid Biosynthesis

Signaling Interplay in Ras Superfamily Function

Live Longer sans the AT1A Receptor

Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer Thomas Winder, Heinz–Josef.

The RAS/MAPK Axis Gets Stressed Out

AKT/PKB Signaling: Navigating the Network

CDK Inhibitors: Cell Cycle Regulators and Beyond

Signal Transduction Through the Epidermal Growth Factor Receptor

AKT/PKB Signaling: Navigating Downstream

Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members Sophie Janssens, Rudi Beyaert Molecular.

SRC and STAT Pathways Journal of Thoracic Oncology

SOCS Proteins, Regulators of Intracellular Signaling

Yan Feng, MD, Praveena S. Thiagarajan, PhD, Patrick C. Ma, MD

mTOR and Akt Signaling in Cancer: SGK Cycles In

Platelet-derived growth factor (PDGF) signalling pathway.

GPC5 Gene and Its Related Pathways in Lung Cancer

Functional Diversity and Regulation of Different Interleukin-1 Receptor-Associated Kinase (IRAK) Family Members Sophie Janssens, Rudi Beyaert Molecular.

Guilty as charged Cancer Cell

Volume 7, Issue 1, Pages 1-11 (July 1997)

Phases of the Cell Cycle

Phases of the Cell Cycle

Brief Review – Growth Factors and Receptors

Cell Signaling by Receptor Tyrosine Kinases

Characterization of the MM.1 human multiple myeloma (MM) cell lines

Successful targeting of ErbB2 receptors—is PTEN the key?

Overview of molecular JAK signaling.

Presentation transcript:

Sustaining Proliferative Signaling and Evading Growth Suppressors Oct 26, 2017

Hallmarks of Cancer, 2011

Epidermal Growth Factor Receptor -EGFR (aka ErbB1 or HER1) -tyrosine kinase receptor -3 other family members (HER2, HER3, HER4) -Binding partners include: -EGF -amphiregulin -neuregulins

EGF Signaling Pathway

Dimerization of EGFR -Conformation change upon binding, allowing domain II to interact -Can form heterodimers with other family members

Dimerization of EGFR -Phosphorylation of each of the Receptors by its partner

Signal Termination Multi-step process Additional phosphorylation, conformation change Inhibits EGF binding Dephosphorylation of tyrosine residues Binging of Negative regulators

Translocation of Proteins to EGFR -EGFR when phosphorylated attracts SH2 domain containing proteins -SH2 – Src homology 2 domain, -Binds to phosphorylated tyrosines -Grb2 – Contains SH2 domain and Binds EGFR-P -Contains a SH3 domain as well -SH3 – Src homology 3 domain -Binds to short proline-rich amino acid sequence -SOS – Son of Sevenless, contains the proline-rich sequence. -Activates RAS

Insulin Receptor Complex

Monomeric GTPases GAP – GTPase-activating protein GEF – Guanine nucleotide exchange factor

RAS Activation -RAS – GTP binding protein SOS GAP – GTPase-activating protein GEF – Guanine nucleotide exchange factor, SOS RAS- becomes farnesylated

Raf Activation -Activated RAS-GTP recruits Raf to the membrane -Raf is typically inhibited and RAS-GTP relieves the inhibition -Activated Raf can then phosphorylate MEK All kinases GTP

MAPK Activation -Activated MEK phosphorylates MAPK -Activated MAPK then enters the nucleus to phosphorylate transcription factors than can then alter their binding GTP

Transcription Factors -MAPK can activate AP-1 -Induces cell cycle progression by activating the Cyclin D gene -Composed of jun and fos proteins can act as a leucine zipper to Bind to DNA

Transcription Factors AP-1 activity in induced by 2 mechanisms: 1. jun becomes phosphorylated 2. MAPK activity increase sthrough other transcription factors the levels of jun and fos

MAPK induces Myc -MAPK targets several of the Myc family transcription Factors Myc family includes: Myc, Max, Mad, Mxi Myc and Max form a heterodimer of a helix-turn-helix leucine zipper Gene targets include: N-Ras and p53 and bind at the E box Max and Mad/Mxi heterodimer inhibit Myc and also bind at the E box but repress transcription

Mad/Mxi Myc Max Max

EGF Signaling Pathway

RAS Interacts with PI3K -Activated RAS brings PI3K to the membrane and converts PIP2 to PIP3 -PIP3 recruits PDK-1 to the membrane

Role of PIP3 -PIP3 recruits PDK-1 to the membrane -PDK-1 phosphorylates Akt

Akt Activities -Activated Akt is involved with anti-apoptotic and survival roles -mTOR, a kinase involved in promoting anabolic programming such as lipid and nucleotide syntheis

Akt Targets

EGF Signaling Pathway